Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
14 hedge funds and large institutions have $954K invested in Novo Integrated Sciences, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
105% more capital invested
Capital invested by funds: $466K → $954K (+$488K)
56% more funds holding
Funds holding: 9 → 14 (+5)
12.05% more ownership
Funds ownership: 1.43% → 13.49% (+12%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$869K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$514K |
| 3 |
Renaissance Technologies
New York
|
+$75.4K |
| 4 |
Millennium Management
New York
|
+$42.2K |
| 5 |
HF
HRT Financial
New York
|
+$14.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$27.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$25K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.02K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$55 |
NVOS Hedge Fund Activity: Q4 2022 in Review
14 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q4 2022, worth a combined $954K — up 105% from $466K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NVOS positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $869K. The largest seller was Vanguard Group, cutting an estimated $27.9K.
- 14 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q4 2022, up from 9 in Q3 2022.
- Funds reported $954K of Novo Integrated Sciences, Inc. Common Stock stock for Q4 2022, up 105% quarter-over-quarter.
- 6 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q4 2022 and 1 closed out, a net change of +5 holders.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q4 2022 was Hudson Bay Capital Management, an estimated $869K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q4 2022 was Vanguard Group, an estimated $27.9K sold.
Based on aggregated 13F filings for Q4 2022.